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INTRODUCTION
Patients in the final stages of diabetic neuropathy need hemodialytic therapy for uremia, and patients with retinopathy frequently become blind as their disease progresses. Islet transplantation can prevent or retard the development of complications associated with diabetes.
Although significant progress has been achieved in the area of islet transplantation, the immunosuppressive therapy used with this technique is not without prob lems. Providing the means for immunoisolation is a po tentially important approach to transplanting islets with out immunosuppressive therapy. Previously, we introduced a diffusion chamber for a bioartificial endo crine pancreas (Bio-AEP). The pancreatic islets or cells contained in the bioartificial devices were isolated from the immune system of the host by a selectively perme able membrane (5, 6, (11) (12) (13) .
This experiment was designed to evaluate whether the diffusion chamber could be a useful tool for the treatment of diabetes by acting as a Bio-AEP for xeno graft implantation without immunosuppressive therapy.
MATERIALS AND METHODS

Diffusion Chamber for Bio-AEP
We previously described a diffusion chamber for use as a Bio-AEP, constructed by placing pancreatic B cells trapped in a mixed matrix in the center of a ring holder sandwiched between semipermeable membranes shielded by silicone (11, 12) .
Mouse insulinoma B cells (MIN6 cells) that had been
developed in a transgenic mouse (harboring the human insulin-promoter gene connected to the SV40 T-antigen gene) were employed as a useful potential source for transplantation (10, 20) .
A composition of the mixed matrix was adjusted to 
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(mg/dl) A nuclepore membrane of pore size 0.1 um was em ployed as the semipermeable membrane, which provided a mechanical barrier between the endocrine pancreas graft and the host immune system (5, 11, 12) .
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Xenoimplantation
Diabetes was induced in 15 Sprague-Dawley rats weighing 180-220 g by IV injection of streptozotocin At the 33rd week after implantation, the BIO-AEPs implanted in each of nine rats were removed from the peritoneal cavity. At the 35th week, the three groups of rats were sacrificed, and their pancreata were examined.
The pancreata were removed from the xenoimplanted rats, the sham-operated rats, and the normal control rats.
Microscopic Observations
The Bio-AEPs and pancreata were fixed in Bouin's fluid for 24 h. After fixation, they were embedded in paraffin blocks, cut in 3-to 4-um sections, stained with hematoxylin-eosin (H&E), and were processed by the Figure 2 . Full-length portraits of: a healthy control rat (upper), an STZ-induced diabetic rat with a Bio-AEP without MIN6 (left, sham operation), and a diabetic rat implanted with the device with MIN6 (right, xenoimplantation). These rats were of the same age. The sham-operated rat has a poorly developed body with a swollen abdomen as a result of diabetic enteropathy. It also has cataracts. In contrast, the xenoimplantated rat appears similar to the normal control rat.
Sternberger peroxidase antiperoxidase (PAP) method.
They were then photographed under a light microscope.
RESULTS
In STZ-induced diabetic rats that received xenografts of MIN6 cell-containing diffusion chambers as Bio-AEPs, a return to normoglycemia was observed up to 33 weeks after implantation, without the use of any im munosuppressant. The fasting blood glucose levels be gan to decline from a preimplantation level of 465 ±31 to 65 ± 10 mg/dl. Also, the body weights of the rats gradually increased, so that the rats came to resemble those in the normal control group. The Bio-AEPs were removed 33 weeks after implantation, which promptly made the rats hyperglycemic again.
In contrast, the rats that received Bio-AEPs without MIN6 cells in sham operations had extremely high glu cose levels and showed immediate decreases in body weight after implantation. They developed cataracts, and their abdomens began to swell because of enteropathy. Their fur became messy as a result of diarrhea ( Figs. 1  and 2) .
At week 333 after implantation, the diffusion cham ber removed from each rat was covered by the greater omentum, and microvessels had proliferated on the sur face of the chamber, but there was no adhesion (Fig. 3) . These chambers were easily removed. The condition of the peritonea of the rats was good. Some of the im planted chambers were seen to be situated next to the liver, while the others were under the spleen or on the bladder. Under microscopic observation, the MIN6 cells were found to be intact inside the chamber (Fig. 4) . The pancreata of the rats in all these groups were removed and examined. In those from the xenoimplanted rats, the exocrine tissues had remained normal and a few pancre atic B cells were seen in the islets, whereas in those from the sham-operated animals, the exocrine tissues had been replaced by fat and no pancreatic B cells were seen in the islets (Fig. 5 ). No insulinoma tissue was ob served in the pancreata of the rats in any group.
DISCUSSION
MIN6 cells derived from a transgenic mouse retain a glucose-stimulated insulin secretion ability similar to that of normal islet cells. They also showed other char acteristics similar to those of normal pancreatic islets and beta cells, such as the properties of transport, phos phorylation, and utilization of glucose (10, 20) . For these reasons, we employed MIN6 cells as a potentially useful Bio-AEP for implantation within a diffusion chamber.
In the present experiment, the MIN6 cells that were embedded into a mixed matrix, to be placed in a diffu sion chamber as a Bio-AEP, had been established over a long period of time. To this was attached a semiperme- Figure 3 . At 33 weeks after implantation, the Bio-AEP was examined. No complications (such as intestinal adhesion, ab scess formation, or fibrotic encapsulation) were around the dif fusion chamber. The chamber was covered by the greater omentum, and microvessels had proliferated on the chamber, but there was no adhesion, so that the chamber could be easily removed. The condition of the peritoneum of the rat was good.
able membrane such as a nuclepore (pore size 0.1 um) to provide a mechanical barrier between the endocrine pancreas graft and the host immune system as described previously (5, 6, (11) (12) (13) . The functional Bio-AEP xeno graft prevented the destruction of the host pancreas, as shown in Figure 5 . Recently, it was reported that the damage to B cells caused by STZ administration in new born rats, which was followed by spontaneous recovery from the neonatal diabetes, was related to the spontane ous reconstitution of insulin reserve over the next 2 weeks (17, 18) . However, the B-cell regeneration was in complete, and the adult rats were left with a depleted Bcell mass (1) (2) (3) . The data obtained in the xenoimplanta tion of Bio-AEP were consistent with the observations in rats that early insulin treatment of STZ diabetic rats with glucose-regulating devices (such as a diffusion chamber for a Bio-AEP) may improve endogenous insu-MIN6 insulin Figure 4 . The MIN6 cells were found to be intact, and no mononuclear cell infiltration in the chamber (top). The MIN6 cells were stained with immunoperoxidase for insulin (bottom).
lin release, and that insulin administration helps to pre vent or delay insulin-dependent diabetes mellitus in sub jects at risk for the disease (4, (7) (8) (9) 19) .
These results should bring closer our final goal, which is effective therapy for diabetic patients.
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Impl. of Bio-AEP 1 l 1 Figure 5 . Pancreata were removed from the rats at week 35 of the experiment and subjected to immunoperoxidase staining for insulin. In the pancreas from the normal control (top), insulin-producing cells occupy the whole of the islets. In the pancreas from the sham-oper ated rat (left), only few islets remain, no pancreatic B cells can be seen, and the exocrine tissues have been replaced by fat (left). In contrast, in the pancreas from the xenoimplantated rat, the islets and exocrine tissues have almost recovered their normal state. A few B cells have appeared on the islets (right).
